Notes
The study was funded by Mundipharma International Limited, UK.
Reference
Hirst A, et al. Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine. European Journal of Health Economics : 11 Apr 2015. Available from: URL: http://dx.doi.org/10.1007/s10198-015-0673-1
Rights and permissions
About this article
Cite this article
Transdermal buprenorphine: lower fracture burden at acceptable cost. PharmacoEcon Outcomes News 729, 30 (2015). https://doi.org/10.1007/s40274-015-2187-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2187-6